3.14600 EUR
0.06
1.87%
Last update Dec 16, 8:06 AM CET
Main market
Day range
3.14600
3.14600
Previous close
3.20600
Open
3.14600
Access this stock data via API
Subscribe
Esperion Therapeutics Inc.
3.15
0.06
1.87%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 74.4M 70.2M 55.4M 58.9M
Cost of revenue 35.2M 24.3M 26.9M 21.8M
Gross profit 39.2M 45.9M 28.5M 37.1M
Operating expense
Research & development 12.0M 6.2M 10.7M 9.4M
Selling general and admin 35.7M 33.7M 36.6M 31.5M
Other operating expenses
Operating income -8.5M 6.0M -18.8M -3.8M
Non operating interest income
Income
Expense 18.8M 17.5M 16.6M 14.0M
Other income expense 577.0K 567.6K 913.6K -405.7K
Pretax income -26.7M -10.8M -34.5M -18.2M
Tax provision
Net income -26.7M -10.8M -34.5M -18.2M
Basic EPS -0.2 0.0 -0.2 -0.1
Diluted EPS -0.2 0.0 -0.2 -0.1
Basic average shares 171.1M 168.4M 167.2M 166.7M
Diluted average shares 171.1M 168.4M 167.2M 166.7M
EBITDA -7.9M 6.6M -17.9M -2.7M
Net income from continuing op. -26.7M -10.8M -34.5M -18.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 24 minutes

13:35
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).